Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK

por de Vries, Sieta T., Denig, Petra, Andrić, Adriana, Dimov Di Giusti, Marina, Ptaszynska-Neophytou, Alicia, Härmark, Linda, Mol, Peter G. M.
Publicado 2021

Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study

por de Vries, Sieta T., Harrison, Judy, Revelle, Patrick, Ptaszynska-Neophytou, Alicia, Radecka, Anna, Ragunathan, Gowthamei, Tregunno, Phil, Denig, Petra, Mol, Peter G. M.
Publicado 2019

Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR

por Pierce, Carrie E., de Vries, Sieta T., Bodin-Parssinen, Stephanie, Härmark, Linda, Tregunno, Phil, Lewis, David J., Maskell, Simon, Van Eemeren, Raphael, Ptaszynska-Neophytou, Alicia, Newbould, Victoria, Dasgupta, Nabarun, Wisniewski, Antoni F. Z., Gama, Sara, Mol, Peter G. M.
Publicado 2019

Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR

por van Stekelenborg, John, Ellenius, Johan, Maskell, Simon, Bergvall, Tomas, Caster, Ola, Dasgupta, Nabarun, Dietrich, Juergen, Gama, Sara, Lewis, David, Newbould, Victoria, Brosch, Sabine, Pierce, Carrie E., Powell, Gregory, Ptaszyńska-Neophytou, Alicia, Wiśniewski, Antoni F. Z., Tregunno, Phil, Norén, G. Niklas, Pirmohamed, Munir
Publicado 2019